GR3007446T3 - - Google Patents

Info

Publication number
GR3007446T3
GR3007446T3 GR930400633T GR930400633T GR3007446T3 GR 3007446 T3 GR3007446 T3 GR 3007446T3 GR 930400633 T GR930400633 T GR 930400633T GR 930400633 T GR930400633 T GR 930400633T GR 3007446 T3 GR3007446 T3 GR 3007446T3
Authority
GR
Greece
Prior art keywords
cryoprecipitate
viruses
factor
ahf
heparin
Prior art date
Application number
GR930400633T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8199005&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3007446(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GR3007446T3 publication Critical patent/GR3007446T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
GR930400633T 1988-05-27 1993-03-23 GR3007446T3 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88108458A EP0343275B1 (de) 1988-05-27 1988-05-27 Verfahren zur Herstellung eines hochreinen, virusfreien Antihämophiliefaktors mittels Chromatographie

Publications (1)

Publication Number Publication Date
GR3007446T3 true GR3007446T3 (enExample) 1993-07-30

Family

ID=8199005

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930400633T GR3007446T3 (enExample) 1988-05-27 1993-03-23

Country Status (5)

Country Link
EP (1) EP0343275B1 (enExample)
AT (1) ATE85220T1 (enExample)
DE (1) DE3878227D1 (enExample)
ES (1) ES2053619T3 (enExample)
GR (1) GR3007446T3 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0367840B1 (de) 1988-11-05 1993-02-03 Octapharma AG Verfahren zur Herstellung eines hochreinen, nicht infektiösen Antihämophiliefaktors mittels Chromatographie
FR2659557A1 (fr) * 1990-03-15 1991-09-20 Fondation Nale Transfusion San Procede de preparation d'une solution concentree de facteur viii.
FR2665364A1 (fr) * 1990-03-15 1992-02-07 Fond Nale Transfusion Sang Procede de preparation d'une solution concentree de facteur viii.
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
FR2681867B1 (fr) * 1991-09-26 1993-12-31 Pasteur Merieux Serums Vaccins Procede de purification du facteur viii et preparations obtenues.
DE4204694C3 (de) * 1992-02-01 1995-10-12 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem Faktor VIII mittels Anionenaustauscher-Chromatographie
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
EP0674531A1 (de) * 1992-12-16 1995-10-04 IMMUNO Aktiengesellschaft Verfahren zur herstellung eines virussicheren biologischen präparates
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
ES2099678B1 (es) * 1995-11-03 1998-02-16 Grifols Grupo Sa Procedimiento para la inactivacion de virus en proteinas.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4478825A (en) * 1983-10-14 1984-10-23 Armour Pharmaceutical Company Warm ethanol method for preparation of low fibrinogen antihemophilic factor
DE3432083A1 (de) * 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
ATE73820T1 (de) * 1986-03-27 1992-04-15 Octapharma Ag Verfahren zur herstellung eines hochgereinigten antihaemophilie-faktors.
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof

Also Published As

Publication number Publication date
ES2053619T3 (es) 1994-08-01
ATE85220T1 (de) 1993-02-15
EP0343275A1 (de) 1989-11-29
EP0343275B1 (de) 1993-02-03
DE3878227D1 (de) 1993-03-18

Similar Documents

Publication Publication Date Title
EP0121976A3 (en) Partially purified osteogenic factor and process for preparing same from demineralized bone or an osteosarcoma
DE3564801D1 (en) Recovery of glycerine from saline waters
DE359593T1 (de) Chromatographische trennung von plasmaproteinen.
NZ330061A (en) Process for recovering growth factors from milk or a milk derivative by separating out an growth factor enriched fraction and then further treating this fraction
NO307613B1 (no) Fremgangsmåte ved gjenvinning av xylose fra oppløsninger
JPS57118520A (en) Method of selectively increasing yield and purity of low temperature precipitation protein
EP0022052A3 (en) Process for the separation and isolation of the ahf fraction, the fibronectin fraction and the von willebrand's ristocetin cofactor fraction from blood plasma
SE8402861D0 (sv) Rening av biologiskt material
ATE85220T1 (de) Verfahren zur herstellung eines hochreinen, virusfreien antihaemophiliefaktors mittels chromatographie.
GR3005037T3 (enExample)
IE820171L (en) Treatment of recovered glass
FI903219A0 (fi) Menetelmä tryptofaanin puhdistamiseksi
AU589569B2 (en) Method for recovering purified growth hormones from genetically engineered microorganisms
ATE43639T1 (de) Verfahren zur entfernung von verunreinigungen aus leukozytinterferon-zubereitungen und das so hergestellte gereinigte leukozytinterferon.
CA2110585A1 (en) Therapeutic fragments of von willebrand factor
DK0504318T3 (da) Udvinding af Bt-endotoxinprotein fra lyserede celleblandinger
PT91711A (pt) Processo de separacao do acido l-2-cetogulonico a partir de um mosto de fermentacao
EP0221566A3 (en) Method for preparing antihemophilic factor (ahf) by cold precipitation and for improving solubility of recovered ahf product
EP0816374A3 (en) A method of preparing a composition containing a high proportion of ganglioside
SE8505451L (sv) Rening av l-fenylalanin
FI903366A0 (fi) Foerfarande foer framstaellning av en mycket ren icke infektioes antihemofilifaktor genom kromatografi.
CA2060505A1 (en) Method for recovering recombinant proteins
CA2022165A1 (en) Albumin purification
AU7671087A (en) Method for purifying and isolating two ionic forms of somatomedin C
ATE171696T1 (de) Verfahren zur verwertung eines schwermetalle enthaltenden und sauren abwassers